LGND
Ligand Pharmaceuticals Inc
Price:  
79.35 
USD
Volume:  
327,715.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LGND WACC - Weighted Average Cost of Capital

The WACC of Ligand Pharmaceuticals Inc (LGND) is 7.4%.

The Cost of Equity of Ligand Pharmaceuticals Inc (LGND) is 7.60%.
The Cost of Debt of Ligand Pharmaceuticals Inc (LGND) is 5.50%.

Range Selected
Cost of equity 6.70% - 8.50% 7.60%
Tax rate 20.90% - 41.60% 31.25%
Cost of debt 4.00% - 7.00% 5.50%
WACC 6.5% - 8.2% 7.4%
WACC

LGND WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.62 0.64
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.70% 8.50%
Tax rate 20.90% 41.60%
Debt/Equity ratio 0.06 0.06
Cost of debt 4.00% 7.00%
After-tax WACC 6.5% 8.2%
Selected WACC 7.4%